Selected research
Industry Research
Smoking Cessation Drugs Industry Research Report 2026
Market perspective
The global Smoking Cessation Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Smoking Cessation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Smoking Cessation Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Smoking Cessation Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Smoking Cessation Drugs include GSK, Dr. Reddy's Laboratories, Fontem Ventures, Kimree Technology, Perrigo Company, Smoke Away, The Harvard Drug Group, Pfizer and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Smoking Cessation Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Smoking Cessation Drugs Market by Company
GSK
Dr. Reddy's Laboratories
Fontem Ventures
Kimree Technology
Perrigo Company
Smoke Away
The Harvard Drug Group
Pfizer
Novartis
Johnson & Johnson
Smoking Cessation Drugs Segment by Type
NRTs Products
Nicotine-Free Products
Smoking Cessation Drugs Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Others
Smoking Cessation Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Smoking Cessation Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Smoking Cessation Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Smoking Cessation Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Smoking Cessation Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Smoking Cessation Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Smoking Cessation Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NRTs Products
- Nicotine-Free Products
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Others
Companies covered
- GSK
- Dr. Reddy's Laboratories
- Fontem Ventures
- Kimree Technology
- Perrigo Company
- Smoke Away
- The Harvard Drug Group
- Pfizer
- Novartis
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Smoking Cessation Drugs Market Size (2021-2032)
- 2.2.2 Global Smoking Cessation Drugs Sales (2021-2032)
- 2.2.3 Global Smoking Cessation Drugs Market Average Price (2021-2032)
- 2.3 Smoking Cessation Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 NRTs Products
- 2.3.3 Nicotine-Free Products
- 2.4 Smoking Cessation Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Smoking Cessation Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Smoking Cessation Drugs Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Smoking Cessation Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Smoking Cessation Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Smoking Cessation Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Smoking Cessation Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Smoking Cessation Drugs, Product Type & Application
- 3.8 Global Manufacturers of Smoking Cessation Drugs, Established Date
- 3.9 Global Smoking Cessation Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Smoking Cessation Drugs Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Dr. Reddy's Laboratories
- 4.2.1 Dr. Reddy's Laboratories Company Information
- 4.2.2 Dr. Reddy's Laboratories Business Overview
- 4.2.3 Dr. Reddy's Laboratories Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dr. Reddy's Laboratories Smoking Cessation Drugs Product Portfolio
- 4.2.5 Dr. Reddy's Laboratories Recent Developments
- 4.3 Fontem Ventures
- 4.3.1 Fontem Ventures Company Information
- 4.3.2 Fontem Ventures Business Overview
- 4.3.3 Fontem Ventures Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fontem Ventures Smoking Cessation Drugs Product Portfolio
- 4.3.5 Fontem Ventures Recent Developments
- 4.4 Kimree Technology
- 4.4.1 Kimree Technology Company Information
- 4.4.2 Kimree Technology Business Overview
- 4.4.3 Kimree Technology Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kimree Technology Smoking Cessation Drugs Product Portfolio
- 4.4.5 Kimree Technology Recent Developments
- 4.5 Perrigo Company
- 4.5.1 Perrigo Company Company Information
- 4.5.2 Perrigo Company Business Overview
- 4.5.3 Perrigo Company Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Perrigo Company Smoking Cessation Drugs Product Portfolio
- 4.5.5 Perrigo Company Recent Developments
- 4.6 Smoke Away
- 4.6.1 Smoke Away Company Information
- 4.6.2 Smoke Away Business Overview
- 4.6.3 Smoke Away Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Smoke Away Smoking Cessation Drugs Product Portfolio
- 4.6.5 Smoke Away Recent Developments
- 4.7 The Harvard Drug Group
- 4.7.1 The Harvard Drug Group Company Information
- 4.7.2 The Harvard Drug Group Business Overview
- 4.7.3 The Harvard Drug Group Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 The Harvard Drug Group Smoking Cessation Drugs Product Portfolio
- 4.7.5 The Harvard Drug Group Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Smoking Cessation Drugs Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Novartis
- 4.9.1 Novartis Company Information
- 4.9.2 Novartis Business Overview
- 4.9.3 Novartis Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Novartis Smoking Cessation Drugs Product Portfolio
- 4.9.5 Novartis Recent Developments
- 4.10 Johnson & Johnson
- 4.10.1 Johnson & Johnson Company Information
- 4.10.2 Johnson & Johnson Business Overview
- 4.10.3 Johnson & Johnson Smoking Cessation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Johnson & Johnson Smoking Cessation Drugs Product Portfolio
- 4.10.5 Johnson & Johnson Recent Developments
5 Global Smoking Cessation Drugs Market Scenario by Region
- 5.1 Global Smoking Cessation Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Smoking Cessation Drugs Sales by Region: 2021-2032
- 5.2.1 Global Smoking Cessation Drugs Sales by Region: 2021-2026
- 5.2.2 Global Smoking Cessation Drugs Sales by Region: 2027-2032
- 5.3 Global Smoking Cessation Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Smoking Cessation Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Smoking Cessation Drugs Revenue by Region: 2027-2032
- 5.4 North America Smoking Cessation Drugs Market Facts & Figures by Country
- 5.4.1 North America Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Smoking Cessation Drugs Sales by Country (2021-2032)
- 5.4.3 North America Smoking Cessation Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Smoking Cessation Drugs Market Facts & Figures by Country
- 5.5.1 Europe Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Smoking Cessation Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Smoking Cessation Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Smoking Cessation Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Smoking Cessation Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Smoking Cessation Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Smoking Cessation Drugs Market Facts & Figures by Country
- 5.7.1 South America Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Smoking Cessation Drugs Sales by Country (2021-2032)
- 5.7.3 South America Smoking Cessation Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Smoking Cessation Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Smoking Cessation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Smoking Cessation Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Smoking Cessation Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Smoking Cessation Drugs Sales by Type (2021-2032)
- 6.1.1 Global Smoking Cessation Drugs Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Smoking Cessation Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Smoking Cessation Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Smoking Cessation Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Smoking Cessation Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Smoking Cessation Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Smoking Cessation Drugs Sales by Application (2021-2032)
- 7.1.1 Global Smoking Cessation Drugs Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Smoking Cessation Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Smoking Cessation Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Smoking Cessation Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Smoking Cessation Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Smoking Cessation Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Smoking Cessation Drugs Value Chain Analysis
- 8.1.1 Smoking Cessation Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Smoking Cessation Drugs Production Mode & Process
- 8.2 Smoking Cessation Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Smoking Cessation Drugs Distributors
- 8.2.3 Smoking Cessation Drugs Customers
9 Global Smoking Cessation Drugs Analyzing Market Dynamics
- 9.1 Smoking Cessation Drugs Industry Trends
- 9.2 Smoking Cessation Drugs Industry Drivers
- 9.3 Smoking Cessation Drugs Industry Opportunities and Challenges
- 9.4 Smoking Cessation Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst